Palleiko Benjamin L Insider Trading Activity
Palleiko Benjamin L has been net-selling over the last 12 months with 0 purchases and 15 sales across 1 company.
KALV is the most-traded position with 15 trades. The largest single transaction was a sale of KALV for $293K on May 22, 2026.
Performance Scorecard
Forward stock performance after each transaction by Palleiko Benjamin L. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -8.0% | 29% | 14 |
| 90 days | — | -26.2% | 15% | 13 |
| 120 days | — | -9.6% | 33% | 9 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKALV · KalVista Pharmaceuticals, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Palleiko Benjamin L bought and sold KALV.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 22, 2026 | KALV | Sell | 10,926 | $26.78 | $293K | −2.2% | CEO | |
May 18, 2026 | KALV | Sell | 1,129 | $26.76 | $30K | −0.2% | CEO | |
May 12, 2026 | KALV | Sell | 3,322 | $26.71 | $89K | −0.7% | CEO | |
Apr 17, 2026 | KALV | Sell | 9,550 | $20.22 | $193K | −2.0% | CEO | |
Mar 9, 2026 | KALV | Sell | 6,693 | $16.08 | $108K | −1.5% | CEO | |
Feb 23, 2026 | KALV | Sell | 10,034 | $15.57 | $156K | −2.2% | CEO | |
Feb 18, 2026 | KALV | Sell | 1,038 | $15.00 | $16K | −0.2% | CEO | |
Feb 12, 2026 | KALV | Sell | 3,354 | $15.70 | $53K | −0.8% | CEO | |
Dec 8, 2025 | KALV | Sell | 7,294 | $16.51 | $120K | −1.7% | CEO | |
Nov 24, 2025 | KALV | Sell | 10,940 | $13.45 | $147K | −2.6% | CEO | |
Nov 18, 2025 | KALV | Sell | 4,466 | $14.48 | $65K | −1.1% | CEO | |
Nov 12, 2025 | KALV | Sell | 3,328 | $11.55 | $38K | −0.8% | CEO | |
Sep 8, 2025 | KALV | Sell | 7,294 | $15.84 | $116K | −1.8% | CEO | |
Aug 22, 2025 | KALV | Sell | 10,940 | $13.22 | $145K | −2.8% | CEO | |
Aug 18, 2025 | KALV | Sell | 4,409 | $13.19 | $58K | −1.2% | CEO | |
Jul 9, 2025 | KALV | Sell | 32,979 | $15.69 | $518K | −8.2% | CEO | |
Jun 9, 2025 | KALV | Sell | 7,169 | $14.50 | $104K | −2.2% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 17 | $2.2M |
Other insiders at KalVista Pharmaceuticals, Inc.
5 other tracked filers at KALV.